Search

Your search keyword '"Eileen W. Stalman"' showing total 15 results

Search Constraints

Start Over You searched for: Author "Eileen W. Stalman" Remove constraint Author: "Eileen W. Stalman" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
15 results on '"Eileen W. Stalman"'

Search Results

1. Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection

2. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

3. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

4. Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination

5. Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273

6. Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

7. SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

8. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants

9. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands

10. Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod

11. Author response: Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273

12. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

13. Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients:To wait and repopulate?

14. Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

15. Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID

Catalog

Books, media, physical & digital resources